VIGILANT X4 CRT-D, Model G247, Sterile. Cardiac Resynchronization Therapy Defibrillators (CR...

FDA Device Recall #Z-0079-2018 — Class II — October 4, 2017

Recall Summary

Recall Number Z-0079-2018
Classification Class II — Moderate risk
Date Initiated October 4, 2017
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Boston Scientific Corporation
Location Saint Paul, MN
Product Type Devices
Quantity 4 devices

Product Description

VIGILANT X4 CRT-D, Model G247, Sterile. Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) are indicated for patients with heart failure who receive stable optimal pharmacologic therapy (OPT) for heart failure and who meet any one of the following classifications: (1) Moderate to severe heart failure (NYHA Class III-IV) with EF d 35% and QRS duration e 120 ms; (2) Left bundle branch block (LBBB) with QRS duration e 130 ms, EF d 30%, and mild (NYHA Class II) ischemic or nonischemic heart failure or asymptomatic (NYHA Class I) ischemic heart failure.

Reason for Recall

The devices have an incorrect firmware configuration.

Distribution Pattern

The devices were distributed to medical facilities located in MN and OH. There was no foreign/government/military distribution.

Lot / Code Information

Serial numbers 174170, 174349, 174598, and 174606.

Other Recalls from Boston Scientific Corporation

Recall # Classification Product Date
Z-1551-2026 Class II EndoVive Safety PEG Kit; Outer Box Material Nu... Feb 10, 2026
Z-1160-2026 Class I AXIOS Stent and Electrocautery-Enhanced Deliver... Dec 19, 2025
Z-1162-2026 Class I *HOT AXIOS Stent and Electrocautery-Enhanced De... Dec 19, 2025
Z-1159-2026 Class I AXIOS Stent and Electrocautery-Enhanced Deliver... Dec 19, 2025
Z-1163-2026 Class I *HOT AXIOS Stent and Electrocautery-Enhanced De... Dec 19, 2025

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.